Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,341
Closed -$5.58K 6509
2025
Q2
$5.58K Sell
12,341
-943,525
-99% -$411K ﹤0.01% 5743
2025
Q1
$389K Sell
955,866
-2,034,776
-68% -$1.31M ﹤0.01% 4956
2024
Q4
$1.98M Sell
2,990,642
-978,449
-25% -$680K ﹤0.01% 3652
2024
Q3
$3.37M Sell
3,969,091
-16,579
-0.4% -$12.7K ﹤0.01% 3194
2024
Q2
$2.66M Buy
3,985,670
+2,095,274
+111% +$1.74M ﹤0.01% 3282
2024
Q1
$2.46M Buy
1,890,396
+1,711,420
+956% +$1.79M ﹤0.01% 3542
2023
Q4
$103K Sell
178,976
-1,402,962
-89% -$970K ﹤0.01% 5344
2023
Q3
$1.19M Sell
1,581,938
-561,700
-26% -$427K ﹤0.01% 4048
2023
Q2
$1.56M Buy
2,143,638
+2,067,766
+2,725% +$1.92M ﹤0.01% 3688
2023
Q1
$57K Sell
75,872
-1,617,218
-96% -$1.5M ﹤0.01% 5584
2022
Q4
$1.63M Buy
1,693,090
+1,606,826
+1,863% +$2.27M ﹤0.01% 3735
2022
Q3
$188K Sell
86,264
-27,159
-24% -$93.7K ﹤0.01% 5691
2022
Q2
$397K Buy
+113,423
New +$424K ﹤0.01% 5137
2021
Q4
Sell
-16,160
Closed -$128K 7438
2021
Q3
$128K Buy
+16,160
New +$133K ﹤0.01% 6327
2021
Q2
Sell
-197,840
Closed -$1.2M 7164
2021
Q1
$1.2M Buy
+197,840
New +$1.52M ﹤0.01% 4035
2020
Q4
Sell
-301,926
Closed -$2.01K 5627
2020
Q3
$2.01K Sell
301,926
-587,869
-66% -$5.24M ﹤0.01% 2591
2020
Q2
$7.88M Buy
889,795
+859,603
+2,847% +$2.47M 0.01% 1382
2020
Q1
$53K Buy
+30,192
New +$38.4K ﹤0.01% 3660
2016
Q2
Sell
-1,477
Closed -$24K 3621
2016
Q1
$24K Sell
1,477
-4,573
-76% -$81.6K ﹤0.01% 3189
2015
Q4
$129K Buy
6,050
+1,505
+33% +$33K ﹤0.01% 3205
2015
Q3
$99K Sell
4,545
-810
-15% -$19.6K ﹤0.01% 3273
2015
Q2
$122K Buy
+5,355
New +$131K ﹤0.01% 3135
2014
Q3
Sell
-1,010
Closed -$32K 4036
2014
Q2
$32K Buy
+1,010
New +$42.2K ﹤0.01% 3316

Other funds holding VXRT

Israel Englander's VXRT Position: Q3 2025 in Review

Israel Englander sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 12,341 shares — an estimated $5.58K sold.

Israel Englander first reported a position in VXRT in Q2 2014 and held it in 23 quarters. The position peaked at $7.88M in Q2 2020. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Israel Englander reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Israel Englander sold 12,341 Vaxart shares in Q3 2025, an estimated $5.58K.
  • Israel Englander first reported a position in Vaxart in Q2 2014 and held it in 23 quarters.
  • Israel Englander's Vaxart position peaked at $7.88M in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.